
|Articles|January 15, 2004
Clear Care claims get OK; prices cut on daily lenses
Atlanta-The FDA has given CIBA Vision permission to print that its Clear Care solution provides clinically significant improvements in frequency of dryness and end-of-day comfort over three multipurpose solutions.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
FDA clears BVI’s FineVision HP trifocal IOL for the US market
2
Treating myopia today: US-focused treatments, challenges, and global insights
3
AAO 2025: A practice’s experience with connecting "the why," building community for techs
4
US FDA awards Epion Therapeutics EpiSmart cross-linking system Fast Track designation
5